SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?


To: Mkilloran who wrote (11498)7/15/1998 10:55:00 AM
From: VLAD  Read Replies (2) | Respond to of 23519
 
martin,

You make a good point. This is why I think that Vivus can realistically get $23.00/share in a buy out. The forward looking PE is for MUSE sales only and a PE of 20 is relatively cheap compared to other similar companies. And they are not just purchasing rights to MUSE but also a new factory, the delivery system patent, ALIBRA and any potential product in the R&D phase.